| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $4.97 (Beat by $1.81) |
| EPS GAAP Actual | $4.97 (Beat by $1.81) |
| Revenue Actual | $2.16621B |
| Revenue Surprise | Beat by $2166.21M |
| Announce Date | 03/29/2026 (Pre-Market) |
| EPS Normalized Estimate | $3.46633 |
| EPS GAAP Estimate | $3.46633 |
| Revenue Estimate | $2.0097527B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 17.61 | 7.95 | 17.07834 | 18.19361 | 1 |
| Dec 2027 | 15.94 | 8.79 | 15.55459 | 16.54217 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 3.86 | 0.47552 | 2.16621B | 4.34% | 106.04M |
| FQ3 2025 (Sep 2025) | 7.09 | 3.98543 | 2308.57B | 99.92% | 2306590.3M |
| FQ2 2025 (Jun 2025) | 7.24 | 7.24 | 1.88675B | 0.52% | 1886.75M |
| FQ1 2025 (Mar 2025) | 3.54 | 3.54 | 2.07703B | 2.84% | 2077.03M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 2.07228B | 16.69% | 2072.28M |
| FQ3 2024 (Sep 2024) | 2 | 2 | 1.94813B | 2.9% | 1948.13M |
| FQ2 2024 (Jun 2024) | 2.33 | 2.33 | 1.87702B | -2.45% | 1877.02M |
| FQ1 2024 (Mar 2024) | 3.02 | 3.02 | 2.01809B | 7.55% | 2018.09M |
FQ4 Announce Date
03/29/2026 (Pre-Market)
Consensus EPS Estimates
3.46633
Consensus Revenue Estimates
2.0097527B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 4.16 | -- | 4.14256 | 4.17744 | 1 |
| FQ3 2027 (Sep 2027) | 4.14 | -- | 4.12264 | 4.15736 | 1 |
| FQ2 2027 (Jun 2027) | 4.01 | -- | 3.99319 | 4.02681 | 1 |
| FQ1 2027 (Mar 2027) | 3.93 | -- | 3.91352 | 3.94648 | 1 |
| FQ4 2026 (Dec 2026) | 3.9039 | 1.12 | 3.79687 | 4.01916 | 1 |
| FQ3 2026 (Sep 2026) | 3.70897 | -91.16 | 3.60728 | 3.81847 | 1 |
| FQ2 2026 (Jun 2026) | 3.5611 | -103.31 | 3.46346 | 3.66624 | 1 |
| FQ1 2026 (Mar 2026) | 3.46633 | -2.13 | 3.4 | 3.5 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.17B | -- | 2.16B | 2.17B | 1 |
| FQ3 2027 (Sep 2027) | 2.18B | -- | 2.17B | 2.18B | 1 |
| FQ2 2027 (Jun 2027) | 2.15B | -- | 2.14B | 2.16B | 1 |
| FQ1 2027 (Mar 2027) | 2.12B | -- | 2.12B | 2.13B | 1 |
| FQ4 2026 (Dec 2026) | 2.09B | -3.68 | 2.05B | 2.14B | 1 |
| FQ3 2026 (Sep 2026) | 2.08B | -111032.02 | 2.03B | 2.12B | 1 |
| FQ2 2026 (Jun 2026) | 2.03B | 6.95 | 1.98B | 2.07B | 1 |
| FQ1 2026 (Mar 2026) | 2.01B | -3.35 | 1.97B | 2.06B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 3.38448 | 3.86 | 0.47552 | 12.32% |
| FQ3 2025 (Sep 2025) | 3.10457 | 7.09 | 3.98543 | 56.21% |
| FQ2 2025 (Jun 2025) | 7.24 | 7.24 | 100% | |
| FQ1 2025 (Mar 2025) | 3.54 | 3.54 | 100% | |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | 2 | 2 | 100% | |
| FQ2 2024 (Jun 2024) | 2.33 | 2.33 | 100% | |
| FQ1 2024 (Mar 2024) | 3.02 | 3.02 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $2.06B | $2.17B | $106.04M | 4.9% |
| FQ3 2025 (Sep 2025) | $1.98B | $2308.57B | $2306590.3M | 99.91% |
| FQ2 2025 (Jun 2025) | $0B | $1.89B | $1886.75M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $2.08B | $2077.03M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2.07B | $2072.28M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.95B | $1948.13M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.88B | $1877.02M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.02B | $2018.09M | 100% |